Meta-analysis: Fact or fiction? How to interpret meta-analyses
暂无分享,去创建一个
Peter Filzmoser | Siegfried Kasper | Klaudius Kalcher | P. Filzmoser | G. Pail | K. Kalcher | S. Kasper | W. Huf | Wolfgang Huf | Gerald Pail | Michaela-Elena Friedrich | M. Friedrich
[1] J. Ioannidis,et al. Relative Citation Impact of Various Study Designs in the Health Sciences , 2005, JAMA.
[2] Julian P T Higgins,et al. Recent developments in meta‐analysis , 2008, Statistics in medicine.
[3] J. Brooks. Why most published research findings are false: Ioannidis JP, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece , 2008 .
[4] H. Möller,et al. Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations , 2010, European Archives of Psychiatry and Clinical Neuroscience.
[5] L. Simpson. Report on Certain Enteric Fever Inoculation Statistics , 1904, British medical journal.
[6] Amit X Garg,et al. Systematic review and meta-analysis: when one study is just not enough. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[7] S G Thompson,et al. Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated , 1994, BMJ.
[8] S. Thompson,et al. Detecting and describing heterogeneity in meta-analysis. , 1998, Statistics in medicine.
[9] H. Möller,et al. How to grade categories of evidence , 2008, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[10] Mark Petticrew,et al. Systematic reviews from astronomy to zoology: myths and misconceptions , 2001, BMJ : British Medical Journal.
[11] D. Bennett. How can I deal with missing data in my study? , 2001, Australian and New Zealand journal of public health.
[12] M. Egger,et al. The hazards of scoring the quality of clinical trials for meta-analysis. , 1999, JAMA.
[13] H. Möller,et al. Meta-analyses: a method to maximise the evidence from clinical studies? , 2010, European Archives of Psychiatry and Clinical Neuroscience.
[14] L. Hedges,et al. The power of statistical tests in meta-analysis. , 2001, Psychological methods.
[15] B. V. Zwieten-Boot,et al. A regulatory Apologia — A review of placebo-controlled studies in regulatory submissions of new-generation antidepressants , 2008, European Neuropsychopharmacology.
[16] J. Higgins,et al. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .
[17] J. Racoosin,et al. Suicidality in pediatric patients treated with antidepressant drugs. , 2006, Archives of general psychiatry.
[18] R. Sysko,et al. Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.
[19] H. Möller,et al. Principle standards and problems regarding proof of efficacy in clinical psychopharmacology , 2010, European Archives of Psychiatry and Clinical Neuroscience.
[20] Robyn M Leventhal,et al. Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database , 2002, Journal of clinical psychopharmacology.
[21] P. Boyle,et al. Beyond classical meta-analysis: can inadequately reported studies be included? , 2004, Drug discovery today.
[22] L. Stewart,et al. To IPD or not to IPD? , 2002, Evaluation & the health professions.
[23] R. Hansen,et al. Controlling for Drug Dose in Systematic Review and Meta-Analysis: A Case Study of the Effect of Antidepressant Dose , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[24] Blair T. Johnson,et al. Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.
[25] Jacob Cohen. Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.
[26] B. Beermann,et al. Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications , 2003, BMJ : British Medical Journal.
[27] J. Schölmerich. Evidence B(i)ased Medicine , 2000, Clinical Oral Investigations.
[28] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[29] Ingram Olkin,et al. Adjusting for publication bias in the presence of heterogeneity , 2003, Statistics in medicine.
[30] S. Thompson,et al. How should meta‐regression analyses be undertaken and interpreted? , 2002, Statistics in medicine.
[31] J. Geddes,et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.
[32] H. Möller,et al. Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. , 2011, The international journal of neuropsychopharmacology.
[33] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.
[34] Ian R White,et al. Imputation methods for missing outcome data in meta-analysis of clinical trials , 2008, Clinical trials.
[35] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[36] Andrea Cipriani,et al. Imputing missing standard deviations in meta-analyses can provide accurate results. , 2006, Journal of clinical epidemiology.
[37] David Rindskopf,et al. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[38] A E Ades,et al. The Interpretation of Random-Effects Meta-Analysis in Decision Models , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.
[39] Dan Jackson,et al. The power of the standard test for the presence of heterogeneity in meta‐analysis , 2006, Statistics in medicine.
[40] R. Waldmann,et al. Placebo, Prozac and PLoS: significant lessons for psychopharmacology , 2011, Journal of psychopharmacology.
[41] Larry V Hedges,et al. The power of statistical tests for moderators in meta-analysis. , 2004, Psychological methods.
[42] N. Freemantle,et al. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. , 2006, Archives of general psychiatry.
[43] P. Gøtzsche,et al. Antidepressant Drug Effects and Depression Severity: A , 2010 .
[44] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[45] R. Poole,et al. Selective publication of antidepressant trials. , 2008, The New England journal of medicine.
[46] D Tritchler,et al. Modelling study quality in meta-analysis. , 1999, Statistics in medicine.
[47] R. Bausell,et al. The Growth of Health-Related Meta-Analyses Published from 1980 to 2000 , 2001, Evaluation & the health professions.
[48] Lucas M. Bachmann,et al. An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary. , 2008, Journal of clinical epidemiology.
[49] P C Lambert,et al. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. , 2002, Journal of clinical epidemiology.
[50] R. DeRubeis,et al. Bias resulting from the use of ‘assay sensitivity’ as an inclusion criterion for meta‐analysis , 2006, Statistics in medicine.
[51] J. Calabrese,et al. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials , 2009, British Journal of Psychiatry.
[52] S Duval,et al. Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.